Zhongzhi Pharmaceutical Holdings マネジメント
マネジメント 基準チェック /34
Zhongzhi Pharmaceutical Holdingsの CEO はYing Feng Laiで、 Mar2021年に任命され、 の在任期間は 3.67年です。 の年間総報酬はCN¥ 1.39Mで、 79%給与と21%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.69%を直接所有しており、その価値はHK$ 5.69M 。経営陣と取締役会の平均在任期間はそれぞれ3.7年と9.4年です。
主要情報
Ying Feng Lai
最高経営責任者
CN¥1.4m
報酬総額
| CEO給与比率 | 79.0% |
| CEO在任期間 | 3.7yrs |
| CEOの所有権 | 0.7% |
| 経営陣の平均在職期間 | 3.7yrs |
| 取締役会の平均在任期間 | 9.4yrs |
経営陣の近況
Recent updates
Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding
Aug 22
Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Jun 19Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation
May 10Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
May 05Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
Apr 21Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares
Feb 01These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
May 24Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?
Aug 26Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet
Apr 28These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
Jun 11Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)
May 06Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues
Apr 21Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?
Mar 29The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More
Mar 05Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Feb 15
What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?
Jan 14Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?
Dec 27If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late
Dec 14Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?
Nov 30Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 17CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥111m |
| Mar 31 2024 | n/a | n/a | CN¥137m |
| Dec 31 2023 | CN¥1m | CN¥1m | CN¥163m |
| Sep 30 2023 | n/a | n/a | CN¥164m |
| Jun 30 2023 | n/a | n/a | CN¥164m |
| Mar 31 2023 | n/a | n/a | CN¥135m |
| Dec 31 2022 | CN¥1m | CN¥802k | CN¥106m |
| Sep 30 2022 | n/a | n/a | CN¥84m |
| Jun 30 2022 | n/a | n/a | CN¥63m |
| Mar 31 2022 | n/a | n/a | CN¥57m |
| Dec 31 2021 | CN¥1m | CN¥791k | CN¥52m |
| Sep 30 2021 | n/a | n/a | CN¥93m |
| Jun 30 2021 | n/a | n/a | CN¥133m |
| Mar 31 2021 | n/a | n/a | CN¥136m |
| Dec 31 2020 | CN¥1m | CN¥801k | CN¥139m |
| Sep 30 2020 | n/a | n/a | CN¥133m |
| Jun 30 2020 | n/a | n/a | CN¥128m |
| Mar 31 2020 | n/a | n/a | CN¥121m |
| Dec 31 2019 | CN¥986k | CN¥700k | CN¥115m |
| Sep 30 2019 | n/a | n/a | CN¥106m |
| Jun 30 2019 | n/a | n/a | CN¥97m |
| Mar 31 2019 | n/a | n/a | CN¥91m |
| Dec 31 2018 | CN¥603k | CN¥274k | CN¥85m |
報酬と市場: Ying Fengの 総報酬 ($USD 191.09K ) は、 Hong Kong市場 ($USD 232.62K ) の同様の規模の企業の平均とほぼ同じです。
報酬と収益: Ying Fengの報酬は 20% 以上増加しましたが、会社の収益は過去 1 年間で 20% 以上減少しました。
CEO（最高経営責任者
Ying Feng Lai (32 yo)
3.7yrs
在職期間
CN¥1,385,000
報酬
Mr. Ying Feng Lai has been Executive Director of Zhongzhi Pharmaceutical Holdings Ltd since May 14, 2018 and serves as its Chief Executive since March 24, 2021. Mr. Lai joined the Group since April 2014 an...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman | 9.8yrs | CN¥1.92m | 60.33% HK$ 495.0m | |
| Chief Executive & Executive Director | 3.7yrs | CN¥1.39m | 0.69% HK$ 5.7m | |
| CFO & Executive Director | 3.7yrs | CN¥1.16m | データなし | |
| Deputy GM & Executive Director | 3.7yrs | CN¥1.36m | 0.38% HK$ 3.1m | |
| Company Secretary | 7.5yrs | データなし | データなし |
3.7yrs
平均在職期間
42yo
平均年齢
経験豊富な経営陣: 3737の経営陣は 経験豊富 であると考えられます ( 3.7年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Chairman | 9.8yrs | CN¥1.92m | 60.33% HK$ 495.0m | |
| Chief Executive & Executive Director | 6.5yrs | CN¥1.39m | 0.69% HK$ 5.7m | |
| CFO & Executive Director | 2.7yrs | CN¥1.16m | データなし | |
| Deputy GM & Executive Director | 9.8yrs | CN¥1.36m | 0.38% HK$ 3.1m | |
| Independent Non-Executive Director | 9.4yrs | CN¥162.00k | データなし | |
| Non-Executive Director | 10.2yrs | CN¥270.00k | 4.89% HK$ 40.1m | |
| Independent Non-Executive Director | 9.4yrs | CN¥162.00k | データなし | |
| Independent Non-Executive Director | 9.4yrs | CN¥162.00k | データなし |
9.4yrs
平均在職期間
56yo
平均年齢
経験豊富なボード: 3737の 取締役会 は 経験豊富 であると考えられます ( 9.4年の平均在任期間)。